|
|
protein dna complex disassembly
|
GO:0032986 |
1 |
1.000
|
|
|
|
nucleosome disassembly
|
GO:0006337 |
1 |
1.000
|
|
|
|
chromatin disassembly
|
GO:0031498 |
1 |
1.000
|
|
|
|
oligosaccharide catabolic process
|
GO:0009313 |
2 |
0.990
|
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.986
|
|
|
|
single species biofilm formation
|
GO:0044010 |
1 |
0.974
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.974
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.970
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.969
|
Mouse |
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.954
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.948
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.941
|
Mouse |
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.936
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.932
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.903
|
Mouse |
|
|
oligosaccharide metabolic process
|
GO:0009311 |
11 |
0.892
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.886
|
Mouse |
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.876
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.872
|
Mouse |
|
|
biofilm formation
|
GO:0042710 |
1 |
0.859
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.847
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.843
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.809
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.799
|
|
|
|
chromatin remodeling at centromere
|
GO:0031055 |
2 |
0.789
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.780
|
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.775
|
|
|
|
dna methylation on cytosine
|
GO:0032776 |
5 |
0.771
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.765
|
Mouse |
|
|
histone modification
|
GO:0016570 |
159 |
0.759
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.740
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.739
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.727
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.716
|
|
|
|
blastocyst growth
|
GO:0001832 |
23 |
0.715
|
|
|
|
negative regulation of neuroblast proliferation
|
GO:0007406 |
7 |
0.694
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.686
|
|
|
|
blastocyst hatching
|
GO:0001835 |
4 |
0.680
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.677
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.662
|
|
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
18 |
0.654
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.642
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.638
|
|
|
|
base excision repair
|
GO:0006284 |
9 |
0.621
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.618
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.611
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.611
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.606
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.598
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.597
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.596
|
|
|
|
anoikis
|
GO:0043276 |
6 |
0.591
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.589
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.582
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.570
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.568
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.551
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.550
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.543
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.528
|
|
|
|
hatching
|
GO:0035188 |
4 |
0.527
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.525
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.524
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.512
|
|
|
|
gonad morphogenesis
|
GO:0035262 |
1 |
0.507
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
27 |
0.495
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.488
|
Mouse |
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.485
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.485
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.468
|
|
|
|
atp dependent chromatin remodeling
|
GO:0043044 |
9 |
0.467
|
Mouse |
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.464
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.462
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.461
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.456
|
Mouse |
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.456
|
|
|
|
positive regulation of cell fate commitment
|
GO:0010455 |
8 |
0.452
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.451
|
|
|
|
positive regulation of reproductive process
|
GO:2000243 |
19 |
0.439
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.439
|
|
|
|
disaccharide metabolic process
|
GO:0005984 |
1 |
0.434
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.425
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.423
|
|
|
|
definitive erythrocyte differentiation
|
GO:0060318 |
7 |
0.415
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.414
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.413
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.404
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.397
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.393
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.389
|
|
|
|
positive regulation of viral process
|
GO:0048524 |
5 |
0.388
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.386
|
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.369
|
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.367
|
Mouse |
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.359
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
18 |
0.359
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.357
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.355
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.351
|
Mouse |
|
|
glial cell fate determination
|
GO:0007403 |
3 |
0.348
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.347
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.327
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.324
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.318
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.317
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.307
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.306
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.305
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.302
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.297
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.292
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.288
|
|
|
|
lens fiber cell apoptotic process
|
GO:1990086 |
4 |
0.285
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.279
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.279
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.279
|
|
|
|
regulation of natural killer cell differentiation
|
GO:0032823 |
11 |
0.277
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.275
|
|
|
|
negative regulation of stem cell proliferation
|
GO:2000647 |
12 |
0.275
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.274
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
18 |
0.273
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.271
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.270
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.267
|
Mouse |
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.264
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.262
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.258
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.251
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.247
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.239
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.235
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.234
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.233
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.232
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.228
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.226
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.224
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.222
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.221
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.220
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.220
|
|
|
|
alcohol catabolic process
|
GO:0046164 |
16 |
0.219
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.219
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.219
|
|
|
|
positive regulation of macroautophagy
|
GO:0016239 |
3 |
0.212
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.207
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.205
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.204
|
|
|
|
regulation of interleukin 2 production
|
GO:0032663 |
28 |
0.198
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.198
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.191
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.189
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.188
|
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
15 |
0.187
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.186
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.184
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.184
|
|
|
|
interaction with symbiont
|
GO:0051702 |
14 |
0.178
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.177
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.175
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.175
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.173
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.172
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.171
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.170
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.169
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.168
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.167
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.165
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.163
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.161
|
|
|
|
vascular smooth muscle cell differentiation
|
GO:0035886 |
11 |
0.160
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.159
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.156
|
|
|
|
response to interleukin 4
|
GO:0070670 |
23 |
0.156
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.149
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.149
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
25 |
0.145
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.145
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.143
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.142
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.142
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.141
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.141
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.137
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.135
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.134
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.133
|
|
|
|
natural killer cell proliferation
|
GO:0001787 |
3 |
0.133
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.133
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
19 |
0.133
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.131
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.131
|
Mouse |
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.129
|
|
|
|
negative regulation of ras protein signal transduction
|
GO:0046580 |
18 |
0.129
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.128
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.127
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.124
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.124
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
GO:0006978 |
2 |
0.124
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.124
|
|
|
|
histone h3 k36 demethylation
|
GO:0070544 |
2 |
0.124
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.122
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.122
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.122
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.122
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.121
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.119
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.119
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.118
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.118
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
27 |
0.118
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
42 |
0.117
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.117
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
9 |
0.117
|
|
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
22 |
0.116
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.113
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.109
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.108
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
9 |
0.107
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.106
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.106
|
|
|
|
methylation dependent chromatin silencing
|
GO:0006346 |
6 |
0.105
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.105
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.104
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.101
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.100
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.100
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.100
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.100
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.100
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.098
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.098
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.097
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.095
|
|
|
|
response to interleukin 15
|
GO:0070672 |
3 |
0.094
|
|
|
|
regulation of cell fate commitment
|
GO:0010453 |
19 |
0.094
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.093
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.092
|
Mouse |
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.090
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.090
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.089
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.088
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.088
|
|
|
|
pharyngeal system development
|
GO:0060037 |
17 |
0.088
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.087
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.087
|
|
|
|
cardiac muscle hypertrophy in response to stress
|
GO:0014898 |
10 |
0.086
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.086
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.085
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.085
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.084
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.084
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.084
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.084
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.083
|
|
|
|
interleukin 2 biosynthetic process
|
GO:0042094 |
15 |
0.082
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.082
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.082
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.081
|
|
|
|
cellular response to interleukin 4
|
GO:0071353 |
21 |
0.081
|
|
|
|
cardiac muscle hypertrophy
|
GO:0003300 |
23 |
0.081
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.080
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.080
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.080
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.079
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.079
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.079
|
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
12 |
0.079
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.078
|
|
|
|
mucosal associated lymphoid tissue development
|
GO:0048537 |
12 |
0.078
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.078
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.077
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.076
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.076
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.075
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.075
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.075
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.074
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.074
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.073
|
|
|
|
glial cell fate commitment
|
GO:0021781 |
14 |
0.073
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.072
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.072
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.071
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.071
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.070
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.070
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.068
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.068
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.068
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.067
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.067
|
|
|
|
progesterone metabolic process
|
GO:0042448 |
4 |
0.066
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.066
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.065
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
40 |
0.065
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.064
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.063
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.063
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.062
|
|
|
|
dna packaging
|
GO:0006323 |
30 |
0.062
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.062
|
|
|
|
regulation of transcription by chromatin organization
|
GO:0034401 |
0 |
0.062
|
|
|
|
cellular response to alcohol
|
GO:0097306 |
23 |
0.061
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.060
|
Mouse |
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.060
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.060
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.059
|
|
|
|
cell volume homeostasis
|
GO:0006884 |
9 |
0.058
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.058
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.058
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
32 |
0.057
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.057
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.056
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.056
|
Mouse |
|
|
cell growth
|
GO:0016049 |
130 |
0.056
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.056
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.055
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.055
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.055
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.055
|
|
|
|
histone lysine demethylation
|
GO:0070076 |
13 |
0.055
|
|
|
|
cellular response to granulocyte macrophage colony stimulating factor stimulus
|
GO:0097011 |
3 |
0.054
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.054
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.054
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.053
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.053
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.053
|
|
|
|
type i interferon signaling pathway
|
GO:0060337 |
10 |
0.052
|
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
28 |
0.052
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.052
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.052
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.051
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.051
|
|
|
|
dna damage response signal transduction resulting in transcription
|
GO:0042772 |
2 |
0.050
|
|
|
|
negative regulation of androgen receptor signaling pathway
|
GO:0060766 |
3 |
0.050
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.050
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.050
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.049
|
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.049
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.049
|
|
|
|
chromatin mediated maintenance of transcription
|
GO:0048096 |
2 |
0.048
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.048
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.048
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.048
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.048
|
Mouse |
|
|
negative regulation of reactive oxygen species biosynthetic process
|
GO:1903427 |
0 |
0.046
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.046
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
3 |
0.046
|
|
|
|
regulation of epidermal growth factor receptor signaling pathway
|
GO:0042058 |
13 |
0.046
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.046
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
20 |
0.046
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.046
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.046
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.045
|
|
|
|
histone demethylation
|
GO:0016577 |
13 |
0.045
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.045
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.044
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.044
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.044
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.044
|
|
|
|
mast cell proliferation
|
GO:0070662 |
4 |
0.044
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.043
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.043
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.043
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.043
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.042
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.042
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.041
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.041
|
|
|
|
interleukin 4 mediated signaling pathway
|
GO:0035771 |
2 |
0.041
|
|
|
|
citrate metabolic process
|
GO:0006101 |
3 |
0.040
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.040
|
|
|
|
regulation of isotype switching to ige isotypes
|
GO:0048293 |
7 |
0.040
|
|
|
|
dna methylation on cytosine within a cg sequence
|
GO:0010424 |
2 |
0.040
|
|
|
|
response to granulocyte macrophage colony stimulating factor
|
GO:0097012 |
3 |
0.039
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.039
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.039
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.039
|
|
|
|
reproductive behavior
|
GO:0019098 |
32 |
0.039
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.038
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.038
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.038
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.037
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.037
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.036
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.035
|
|
|
|
interleukin 2 production
|
GO:0032623 |
33 |
0.035
|
|
|
|
regulation of mast cell proliferation
|
GO:0070666 |
4 |
0.035
|
|
|
|
cd4 positive alpha beta t cell lineage commitment
|
GO:0043373 |
6 |
0.035
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.035
|
|
|
|
positive regulation of epidermal growth factor receptor signaling pathway
|
GO:0045742 |
5 |
0.035
|
|
|
|
negative regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032435 |
15 |
0.034
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.034
|
|
|
|
protein demethylation
|
GO:0006482 |
13 |
0.034
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.034
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.034
|
|
|
|
t cell anergy
|
GO:0002870 |
4 |
0.034
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.033
|
|
|
|
negative regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903051 |
22 |
0.033
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.033
|
Mouse |
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.033
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.033
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.033
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.033
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.033
|
|
|
|
response to interleukin 2
|
GO:0070669 |
2 |
0.032
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.032
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.032
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.032
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.032
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
13 |
0.031
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.031
|
|
|
|
spindle organization
|
GO:0007051 |
28 |
0.031
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.031
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
26 |
0.031
|
|
|
|
positive regulation of lymphocyte anergy
|
GO:0002913 |
4 |
0.031
|
|
|
|
jak stat cascade involved in growth hormone signaling pathway
|
GO:0060397 |
4 |
0.031
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.030
|
|
|
|
natural killer cell differentiation
|
GO:0001779 |
21 |
0.030
|
|
|
|
regulation of transcription elongation from rna polymerase ii promoter
|
GO:0034243 |
9 |
0.030
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.030
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.030
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.030
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.030
|
|
|
|
positive regulation of autophagy
|
GO:0010508 |
9 |
0.030
|
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.030
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.030
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.030
|
Mouse |
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.030
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.030
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.030
|
|
|
|
positive regulation of t cell anergy
|
GO:0002669 |
4 |
0.030
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
24 |
0.029
|
|
|
|
regulation of t cell anergy
|
GO:0002667 |
4 |
0.029
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.029
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.029
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.029
|
|
|
|
terminal button organization
|
GO:0072553 |
3 |
0.028
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.028
|
|
|
|
creatinine metabolic process
|
GO:0046449 |
3 |
0.028
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.028
|
|
|
|
positive regulation of atp biosynthetic process
|
GO:2001171 |
2 |
0.028
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.027
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.027
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.027
|
Mouse |
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.027
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.027
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.027
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.027
|
|
|
|
multicellular organismal reproductive behavior
|
GO:0033057 |
23 |
0.027
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.026
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.026
|
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.026
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.026
|
|
|
|
regulation of dna binding
|
GO:0051101 |
39 |
0.026
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.026
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.026
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.026
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.026
|
|
|
|
regulation of natural killer cell proliferation
|
GO:0032817 |
2 |
0.026
|
|
|
|
negative regulation of interleukin 2 production
|
GO:0032703 |
8 |
0.025
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.025
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.025
|
|
|
|
regulation of carbohydrate catabolic process
|
GO:0043470 |
12 |
0.025
|
|
|
|
negative regulation of glycolytic process
|
GO:0045820 |
4 |
0.025
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.025
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.025
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.024
|
Mouse |
|
|
regulation of lymphocyte anergy
|
GO:0002911 |
4 |
0.024
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.024
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.024
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.024
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.023
|
|
|
|
heterochromatin assembly
|
GO:0031507 |
2 |
0.023
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.023
|
|
|
|
isotype switching to ige isotypes
|
GO:0048289 |
7 |
0.023
|
|
|
|
positive regulation of mrna 3 end processing
|
GO:0031442 |
5 |
0.023
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.023
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.023
|
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.023
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.023
|
|
|
|
cellular response to type i interferon
|
GO:0071357 |
10 |
0.023
|
|
|
|
protein dealkylation
|
GO:0008214 |
13 |
0.022
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.022
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.022
|
|
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.022
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.022
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.022
|
Mouse |
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.022
|
|
|
|
succinate metabolic process
|
GO:0006105 |
4 |
0.022
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.022
|
|
